COMPREHENSIVE EVALUATION OF IMMUNE FUNCTION IN PATIENTS RECEIVING MULTIMODAL THERAPY FOR HIGH-RISK NEUROBLASTOMA

$1,419,453FY2022Department of the ArmyDOD

University Health Network, Toronto ON

Investigators